Payment overview · 2025
General Payments
$137.00
8 reported records · 6 companies
Healthcare provider profile · identity verified
Jason E Griffin, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · THOMASVILLE, GA · NPI 1063485068
Verified facts
What the public records show
CMS Open Payments records show Jason E Griffin, M.D. received $137.00 in general payments during 2025 across 8 reported records.
Novo Nordisk Inc accounted for 25.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Trelegy Ellipta.
Astellas Pharma US Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Myrbetriq as an associated drug or biological on 16 records involving 16 distinct recipient NPIs. Public Medicare Part D data also shows 107 claims for Myrbetriq by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Trelegy Ellipta by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Fiasp as an associated drug or biological on 15 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Fiasp by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Tresiba as an associated drug or biological on 415 records involving 264 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Tresiba by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 655 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $35.34 | 25.8% | 2 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $29.37 | 21.4% | 2 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $20.46 | 14.9% | 1 | 2025 |
| Astellas Pharma US Inc | Unresolved — no canonical attribution shown | $20.18 | 14.7% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $18.14 | 13.2% | 1 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $13.51 | 9.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $137.00 | 8 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $35.34 | 2 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $35.34 | 2 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $29.37 | 2 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $20.46 | 1 | 2025 |
Source payment records
|
|||||
| Veozah Normalized: veozah |
Drug | Astellas Pharma US Inc | $20.18 | 1 | 2025 |
Source payment records
|
|||||
| VYNDAQEL Normalized: vyndaqel |
Drug | PFIZER INC. | $18.14 | 1 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $13.51 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 26 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 24 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Astellas Pharma US Inc Exact reporting entity; no affiliate inference |
2025 | Myrbetriq open payments reported associated product |
CMS Open Payments — General Payments 16 supporting records · 16 recipient NPIs · example record 1238599014 |
Myrbetriq · 2024 Exact normalized brand match · 1 Part D row |
107 | suppressed by CMS |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
24 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Fiasp open payments reported associated product |
CMS Open Payments — General Payments 15 supporting records · 15 recipient NPIs · example record 1188262936 |
Fiasp · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Tresiba open payments reported associated product |
CMS Open Payments — General Payments 415 supporting records · 264 recipient NPIs · example record 1188130328 |
Tresiba · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
655 | 57 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1583 | 199 |
| Amlodipine Besylate | Amlodipine Besylate | 1049 | 146 |
| Gabapentin | Gabapentin | 888 | 95 |
| Furosemide | Furosemide | 820 | 98 |
| Levothyroxine Sodium | Levothyroxine Sodium | 694 | 73 |
| Famotidine | Famotidine | 660 | 72 |
| Eliquis | Apixaban | 655 | 57 |
| Pantoprazole Sodium | Pantoprazole Sodium | 547 | 92 |
| Metoprolol Tartrate | Metoprolol Tartrate | 535 | 59 |
| Potassium Chloride | Potassium Chloride | 527 | 66 |
| Donepezil Hcl | Donepezil Hcl | 526 | 45 |
| Clopidogrel | Clopidogrel Bisulfate | 515 | 49 |
| Trazodone Hcl | Trazodone Hcl | 496 | 63 |
| Hydralazine Hcl | Hydralazine Hcl | 475 | 67 |
| Lisinopril | Lisinopril | 472 | 68 |
| Metformin Hcl | Metformin Hcl | 435 | 67 |
| Levetiracetam | Levetiracetam | 399 | 30 |
| Tamsulosin Hcl | Tamsulosin Hcl | 395 | 63 |
| Carvedilol | Carvedilol | 380 | 52 |
| Quetiapine Fumarate | Quetiapine Fumarate | 374 | 28 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 368 | 73 |
| Losartan Potassium | Losartan Potassium | 368 | 53 |
| Omeprazole | Omeprazole | 354 | 62 |
| Tramadol Hcl | Tramadol Hcl | 342 | 68 |
| Mirtazapine | Mirtazapine | 315 | 43 |
| Sertraline Hcl | Sertraline Hcl | 314 | 27 |
| Citalopram Hbr | Citalopram Hydrobromide | 304 | 41 |
| Metoprolol Succinate | Metoprolol Succinate | 290 | 33 |
| Duloxetine Hcl | Duloxetine Hcl | 280 | 30 |
| Buspirone Hcl | Buspirone Hcl | 276 | 21 |
| Lorazepam | Lorazepam | 266 | 49 |
| Escitalopram Oxalate | Escitalopram Oxalate | 256 | 24 |
| Tizanidine Hcl | Tizanidine Hcl | 246 | 44 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 231 | 59 |
| Montelukast Sodium | Montelukast Sodium | 217 | 28 |
| Prednisone | Prednisone | 216 | 76 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 211 | 38 |
| Allopurinol | Allopurinol | 206 | 31 |
| Simvastatin | Simvastatin | 197 | 30 |
| Januvia | Sitagliptin Phosphate | 170 | 16 |
| Glimepiride | Glimepiride | 167 | 36 |
| Sucralfate | Sucralfate | 164 | 16 |
| Baclofen | Baclofen | 152 | 13 |
| Spironolactone | Spironolactone | 142 | 18 |
| Entresto | Sacubitril/Valsartan | 141 | 16 |
| Aripiprazole | Aripiprazole | 140 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 140 | 45 |
| Warfarin Sodium | Warfarin Sodium | 138 | suppressed |
| Memantine Hcl | Memantine Hcl | 136 | 15 |
| Bumetanide | Bumetanide | 135 | 18 |
| Hydrochlorothiazide | Hydrochlorothiazide | 135 | 32 |
| Meloxicam | Meloxicam | 135 | 36 |
| Ondansetron Hcl | Ondansetron Hcl | 128 | 56 |
| Pravastatin Sodium | Pravastatin Sodium | 126 | 16 |
| Divalproex Sodium | Divalproex Sodium | 124 | suppressed |
| Atenolol | Atenolol | 121 | 17 |
| Alprazolam | Alprazolam | 118 | 20 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 115 | 25 |
| Alendronate Sodium | Alendronate Sodium | 107 | 15 |
| Myrbetriq | Mirabegron | 107 | suppressed |
| Risperidone | Risperidone | 107 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 100 | 19 |
| Terazosin Hcl | Terazosin Hcl | 98 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 95 | suppressed |
| Nifedipine Er | Nifedipine | 93 | 21 |
| Novolog | Insulin Aspart | 91 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 91 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 90 | 22 |
| Metoclopramide Hcl | Metoclopramide Hcl | 90 | suppressed |
| Ezetimibe | Ezetimibe | 88 | 11 |
| Clonidine Hcl | Clonidine Hcl | 87 | 17 |
| Farxiga | Dapagliflozin Propanediol | 86 | 13 |
| Levemir | Insulin Detemir | 84 | 22 |
| Xarelto | Rivaroxaban | 84 | suppressed |
| Lamotrigine | Lamotrigine | 80 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 80 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 76 | 33 |
| Amoxicillin | Amoxicillin | 75 | 59 |
| Clonazepam | Clonazepam | 75 | suppressed |
| Pregabalin | Pregabalin | 75 | 14 |
| Finasteride | Finasteride | 73 | 14 |
| Jardiance | Empagliflozin | 73 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 71 | suppressed |
| Colchicine | Colchicine | 70 | 13 |
| Olanzapine | Olanzapine | 70 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 66 | suppressed |
| Glipizide | Glipizide | 66 | suppressed |
| Mupirocin | Mupirocin | 66 | 26 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 65 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 64 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 64 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 62 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 61 | 42 |
| Primidone | Primidone | 61 | suppressed |
| Lansoprazole | Lansoprazole | 60 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 59 | 34 |
| Tradjenta | Linagliptin | 58 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 57 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 57 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 57 | 13 |
| Latanoprost | Latanoprost | 56 | 13 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 56 | 14 |
| Diltiazem Hcl | Diltiazem Hcl | 53 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 53 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 53 | suppressed |
| Celecoxib | Celecoxib | 52 | 14 |
| Doxepin Hcl | Doxepin Hcl | 52 | suppressed |
| Levemir Flexpen | Insulin Detemir | 51 | 14 |
| Ranolazine Er | Ranolazine | 51 | suppressed |
| Digoxin | Digoxin | 50 | suppressed |
| Linzess | Linaclotide | 50 | 17 |
| Benztropine Mesylate | Benztropine Mesylate | 49 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 48 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 45 | 11 |
| Lovastatin | Lovastatin | 45 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 45 | suppressed |
| Gemfibrozil | Gemfibrozil | 44 | suppressed |
| Haloperidol | Haloperidol | 44 | suppressed |
| Humalog | Insulin Lispro | 43 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 43 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 42 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 39 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 37 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 36 | 23 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 36 | 20 |
| Labetalol Hcl | Labetalol Hcl | 36 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 36 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 35 | suppressed |
| Fluconazole | Fluconazole | 34 | 17 |
| Gemtesa | Vibegron | 34 | suppressed |
| Torsemide | Torsemide | 33 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 33 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 33 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 32 | 24 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 32 | suppressed |
| Paliperidone Er | Paliperidone | 32 | suppressed |
| Lubiprostone | Lubiprostone | 31 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 30 | 21 |
| Bupropion Hcl Sr | Bupropion Hcl | 30 | suppressed |
| Ibuprofen | Ibuprofen | 30 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 30 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 29 | 17 |
| Azithromycin | Azithromycin | 28 | 20 |
| Ipratropium Bromide | Ipratropium Bromide | 28 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 28 | suppressed |
| Trulicity | Dulaglutide | 28 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 27 | suppressed |
| Cephalexin | Cephalexin | 27 | 22 |
| Pioglitazone Hcl | Pioglitazone Hcl | 27 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Anastrozole | Anastrozole | 26 | suppressed |
| Carbamazepine | Carbamazepine | 26 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 26 | suppressed |
| Felodipine Er | Felodipine | 26 | suppressed |
| Hydrocortisone | Hydrocortisone | 26 | 19 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 26 | suppressed |
| Ozempic | Semaglutide | 26 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 26 | suppressed |
| Valsartan | Valsartan | 26 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 21 |
| Clonidine | Clonidine | 25 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 25 | suppressed |
| Methylprednisolone | Methylprednisolone | 25 | 23 |
| Nystatin | Nystatin | 25 | 19 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 25 | suppressed |
| Scopolamine | Scopolamine | 25 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 25 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 24 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 24 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 24 | suppressed |
| Novolin R | Insulin Regular, Human | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 24 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 23 | suppressed |
| Humulin R | Insulin Regular, Human | 23 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 23 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 23 | suppressed |
| Novolog Flexpen | Insulin Aspart | 23 | suppressed |
| Tobramycin Sulfate | Tobramycin Sulfate | 23 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 22 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 22 | 13 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 22 | suppressed |
| Lactulose | Lactulose | 22 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 22 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 22 | suppressed |
| Nystop | Nystatin | 22 | 12 |
| Phenobarbital | Phenobarbital | 22 | suppressed |
| Synthroid | Levothyroxine Sodium | 22 | suppressed |
| Temazepam | Temazepam | 22 | suppressed |
| Acarbose | Acarbose | 21 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 21 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 21 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 21 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 21 | suppressed |
| Topiramate | Topiramate | 21 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 20 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Dutasteride | Dutasteride | 19 | suppressed |
| Premarin | Estrogens, Conjugated | 19 | suppressed |
| Verapamil Er | Verapamil Hcl | 19 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 18 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 17 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 17 | suppressed |
| Klor-Con M10 | Potassium Chloride | 17 | suppressed |
| Levofloxacin | Levofloxacin | 17 | 13 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 16 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 16 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 16 | suppressed |
| Restasis | Cyclosporine | 16 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 16 | suppressed |
| Timolol Maleate | Timolol Maleate | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 16 | suppressed |
| Diazepam | Diazepam | 15 | suppressed |
| Enulose | Lactulose | 15 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 15 | suppressed |
| Azathioprine | Azathioprine | 14 | suppressed |
| Calcitriol | Calcitriol | 14 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 14 | suppressed |
| Fentanyl | Fentanyl | 14 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 14 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 14 | suppressed |
| Livalo | Pitavastatin Calcium | 14 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 14 | suppressed |
| Movantik | Naloxegol Oxalate | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Travoprost | Travoprost | 14 | suppressed |
| Budesonide | Budesonide | 13 | suppressed |
| Modafinil | Modafinil | 13 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Tresiba | Insulin Degludec | 13 | suppressed |
| Acetazolamide | Acetazolamide | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Erythromycin | Erythromycin Base | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 12 | suppressed |
| Nexium | Esomeprazole Magnesium | 12 | suppressed |
| Ondansetron Odt | Ondansetron | 12 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Enbrel Sureclick | Etanercept | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 11 | suppressed |
| Methadone Hcl | Methadone Hcl | 11 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 11 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 11 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 11 | suppressed |
| Ramelteon | Ramelteon | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Valproic Acid | Valproic Acid | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $137.00 · 8 records | Novo Nordisk Inc | AUSTEDO XR, Dexcom G6 Transmitter, Ozempic, Rybelsus, TRELEGY ELLIPTA, VYNDAQEL, Veozah | 6 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Astellas Pharma US Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error